ArticleNeoplasia (New York, N.Y.)2018

Corrigendum to "Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis" [Neoplasia 19.9 (2017) 716-733].

Swetha Tati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.